NOW WE CAN
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98910459
- Mark type
- Stylized text
- Filed
- 18 Dec 2024
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Jennifer M. Mikulina
Goods and services
- Class 042 — Scientific and technological services: Research, development, and design of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine design, discovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligence, namely, data automation and collection service using proprietary software to evaluate, analyze and collect biological data for research and scientific purposes; computer assisted molecule design involving the use of artificial intelligence technology, namely, product design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug development, namely, scientific research in the field of pharmaceuticals; providing online non-downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with pharmaceutical drug discovery, drug development, pharmaceutical market access, chemogenomics, toxicogenomics and drug response prediction; providing online non-downloadable self-learning and artificial intelligence software for use in the field of healthcare for molecular research, research and development of pharmaceutical products and chemical compounds, cell analysis, design of chemical structures, and analysis of biological or chemical activity; providing online non-downloadable software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules
Owner
- Generate Biomedicines, Inc., Somerville, MA, US
- Generate Biomedicines, Inc., Somerville, MA, US
Prosecution history
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 11 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 11 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 04 Aug 2025 — ASSIGNED TO EXAMINER
- 12 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Jun 2025 — NON-FINAL ACTION E-MAILED